Source: CEPOP

This meeting featured discussion of prescription drug monitoring program interoperability, the role of naloxone in CPR & AED “Heartsaver” training, a recap of the CEPOP – Advocates for Opioid Recovery Hill Briefing (November 15), and the Administration report on DEA Take Back Day.

The CEPOP All-Participants Monthly Teleconference took place Monday, November 27 from 3:00 p.m. – 4:00 p.m. ET.

Below is the agenda of the items covered and a downloadable copy of the agenda document.


I. Welcome

II. Focus Topics

A. Prescription Drug Monitoring Program Interoperability 
Danna Droz, JD, RPh, Prescription Monitoring Program Liaison, National Association of Boards of Pharmacy

B. The Role of Naloxone in CPR & AED 
Lara Gent, Ph.D., Director of Community Markets and Programs, American Heart Association

III. Advocacy and Policy Priorities

A. Next Steps for the Administration’s Response

i. Declaration of a Public Health Emergency

ii. The President’s Opioid Commission Report Final Report

B. FY2018 Budget Update

C. CEPOP – Advocates for Opioid Recovery Hill Briefing Recap (November 15) – Video Recording

IV. Working Groups

A. Takeback and Anti-Diversion

i. FDA Public Workshop on Packaging, Storing and Disposal Options (December 11-12)

ii. Administrative Report on DEA Take Back Day

B. Safe Use and Prevention

i. FDA and CMS Meeting Requests

ii. Policy Initiatives

  1. Access to High-Quality SUD Treatment & Recovery Services Roundtable (January 2018)
  2. Proposed Roundtable on Safer Pain Management

V. Organizational Updates (Recent and Upcoming Events)

A. TFAH  – WBT Pain in the Nation Report Release

B. Sharing Intel, Participant News and Updates

Annual CEPOP All-Participants Strategy Session (In-Person): Monday, December 18, 2017, 3:00 pm – 5:00 pm EST

Download the agenda.